Atea Pharmaceuticals Q2 EPS $(0.44) Misses $(0.43) Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings MissesNews
Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.43) by 2.33 percent. This is a 8.33 percent increase over losses of $(0.48) per share
Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.43) by 2.33 percent. This is a 8.33 percent increase over losses of $(0.48) per share from the same period last year.